<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Ny analyse fra ØU på Onkology Venture]]></title><description><![CDATA[<p dir="auto">Ny analyse fra Steen Albrechtsen fra Økonomisk Ugebrev - Biotech.</p>
<p dir="auto"><a href="http://oncologyventure.com/wp-content/uploads/2019/01/Oncology-Venture-%C3%98konomisk-Ugebrev-Biotech-21-2018.pdf" rel="nofollow ugc">http://oncologyventure.com/wp-content/uploads/2019/01/Oncology-Venture-Økonomisk-Ugebrev-Biotech-21-2018.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/440030/ny-analyse-fra-u-p-onkology-venture</link><generator>RSS for Node</generator><lastBuildDate>Wed, 15 Jul 2026 21:35:33 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/440030.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 08 Jan 2019 18:22:47 GMT</pubDate><ttl>60</ttl></channel></rss>